Astrazeneca shares jump as it kicks off $2bn drug pipeline investment
Astrazeneca’s share jumped in early trading on Friday, as investors cheered plans to bolster its drug pipeline. The pharmaceutical giant’s shares increased 3.1 per cent to £134.50 on Friday morning, as it launched a $2bn (£1.5bn) restructuring programme to boost investment in its drug channel. The FTSE 100 company said the three-year programme would shift [...]
Continue reading this story on City A.M., the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.